Continuum Advisory’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.2K Buy
+319
New +$27.1K ﹤0.01% 982
2025
Q2
Sell
-61
Closed -$4.46K 860
2025
Q1
$4.46K Buy
61
+25
+69% +$2.07K ﹤0.01% 1136
2024
Q4
$2.98K Sell
36
-3
-8% -$237 ﹤0.01% 1287
2024
Q3
$3.16K Buy
39
+9
+30% +$635 ﹤0.01% 1288
2024
Q2
$2.06K Hold
30
﹤0.01% 1293
2024
Q1
$1.93K Buy
+30
New +$1.61K ﹤0.01% 1310

Other funds holding GMED

Continuum Advisory's GMED Position: Q2 2026 in Review

Continuum Advisory opened a new position in Globus Medical (GMED) in Q2 2026: 319 shares worth $25.2K. The stake represents ﹤0.01% of the portfolio and ranks #982 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in GMED as recently as Q1 2025.

Continuum Advisory first reported a position in GMED in Q1 2024 and has held it in 6 quarters since. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Continuum Advisory held 319 shares of Globus Medical worth $25.2K as of Q2 2026.
  • Globus Medical was a new Continuum Advisory position in Q2 2026.
  • Globus Medical made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #982 holding.
  • Continuum Advisory first reported a position in Globus Medical in Q1 2024 and has held it in 6 quarters since.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.